推出早期低剂量皮治疗后极度早产新生儿的结果:一项回顾性病例控制研究
Ellie Purcell1, Pooja Sachdev2, Dushyant Batra3
1School of Medicine, University of Nottingham, United Kingdom of Great Britain and Northern Ireland.
Early human development
|December 24, 2025
概括
早期低剂量皮醇 (ELDH) 在极度早产婴儿中没有改善无支气管肺功能失调 (BPD) 的生存率. ELDH与败血症增加和更长时间的呼吸支持需求有关.
科学领域:
- 新生儿医学 新生儿医学
- 儿科重症监护 儿科重症监护
- 药理学 药理学是指药理学的学科.
背景情况:
- 极度早产的新生儿面临高风险的支气管肺功能障碍症 (BPD).
- 早期低剂量皮质 (ELDH) 作为一种潜在的干预措施正在探索中.
- 普雷米洛克研究方案指导ELDH在出生后24小时内给予.
研究的目的:
- 评估ELDH使用和36周完成妊娠年龄 (CGA) 的无BPD生存率之间的关联.
- 评估二次结果,包括死亡率,败血症和呼吸支持续时间.
主要方法:
- 追溯,匹配的病例控制研究,涉及188名极度早产新生儿.
- 病例在24小时内接受了ELDH (在10天内8.5毫克/公斤).
- 对照组没有接受ELDH;数据来自三级新生儿重症监护室收集.
主要成果:
- 没有ELDH和改善BPD无生存率 (p=0.153) 或降低死亡率 (p=0.814) 之间的显著关联.
- 使用ELDH显着与培养阳性晚发性败血症的增加有关 (p=0.006).
- 较高的非侵入性呼吸支天数 (p=0.032) 和较长的总停留时间 (p=0.004) 被观察到与ELDH.
结论:
- 在极度早产新生儿中,ELDH并没有提高BPD无生存率.
- 使用ELDH与败血症发病率增加和呼吸支持续时间相关.
- 需要进一步的研究来确定可能受益于ELDH的早产新生儿.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405
COPD: Management Using Bronchodilators and Corticosteroids
698
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
698
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
376
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
376
Nephrotic Syndrome II : Assessment and Medical Management
179
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
179


